Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Neuroimaging Study of Exercise and Memory Function (EMF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02057354
Recruitment Status : Completed
First Posted : February 7, 2014
Last Update Posted : April 25, 2018
Sponsor:
Collaborator:
National Institute on Aging (NIA)
Information provided by (Responsible Party):
Karin Schon, Boston University

Brief Summary:
The investigators are examining the effects of exercise and cardiovascular fitness on cognitive processes, brain function, and the amount of several proteins in the blood. These proteins include a hormone called cortisol, also known as the "stress hormone," and a growth factor called "brain-derived neurotrophic factor" (BDNF). The "stress hormone" cortisol is produced by the adrenal glands. Stress, exercise, obesity, and other factors may influence cortisol levels. BDNF is a protein that promotes the health of nerve cells in the brain and in the body. It plays a role in the growth, maturation, and maintenance of these cells. The amount of this protein in blood samples is therefore an indicator of healthy nerve cell function. Here, the investigators are investigating if exercise improves brain function by changing BDNF levels. Participation in this research study will take approximately 4 months. During this time, participants will make four initial study visits. The first visit is for informed consent and screening, the second and third visits are for baseline fitness testing, and the fourth visit is for a blood draw, cognitive testing, and a functional Magnetic Resonance Imaging (fMRI) exam. Functional MRI is a brain imaging technique that uses a magnetic field to "take pictures" of the brain while a person performs a given task. It will take up to approximately three weeks to complete these initial four study visits. Following the four initial study visits, the exercise-training program will begin. Participants will be randomized to one of two training programs: an aerobic exercise program and a non-aerobic exercise program consisting of strengthening, balance and stretching exercises. The exercise training program will last 12 weeks. There will be three one-hour exercise sessions per week. After completion of the exercise-training program, participants will attend three follow-up study visits. The first two follow-up visits are for fitness testing. The third and final follow-up visit is for a blood draw, cognitive testing, and an MRI exam.

Condition or disease Intervention/treatment Phase
Aging Behavioral: Aerobic Exercise Behavioral: Non-Aerobic Exercise Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 190 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Aerobic Exercise, Neurotrophins, and fMRI of Hippocampal Function and Structure
Actual Study Start Date : April 2014
Actual Primary Completion Date : January 2018
Actual Study Completion Date : March 2018

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Healthy Sedentary Young Adults
Participants 18-35 years of age will be randomized to either aerobic or non-aerobic exercise training.
Behavioral: Aerobic Exercise
The goal of the aerobic exercise training is to increase aerobic endurance. Walking on treadmill at moderate intensity with grade adjusted. Exercise tailored to individual ability level.
Other Name: Endurance Training

Behavioral: Non-Aerobic Exercise
The goal of this training is to improve overall muscle strength, balance and flexibility. Participants will do strength, balance and stretching exercises. Exercises tailored to individual ability level.
Other Name: Strength, balance, stretching

Experimental: Healthy Sedentary Older Adults
Participants 55-85 years of age will be randomized to either aerobic or non-aerobic exercise training.
Behavioral: Aerobic Exercise
The goal of the aerobic exercise training is to increase aerobic endurance. Walking on treadmill at moderate intensity with grade adjusted. Exercise tailored to individual ability level.
Other Name: Endurance Training

Behavioral: Non-Aerobic Exercise
The goal of this training is to improve overall muscle strength, balance and flexibility. Participants will do strength, balance and stretching exercises. Exercises tailored to individual ability level.
Other Name: Strength, balance, stretching




Primary Outcome Measures :
  1. MRI [ Time Frame: 1.5 to 2 hours each at Visits 4 and 43 ]
    Measurement of brain activity during task performance and measurement of change in regional brain volumes.

  2. Serum BDNF level [ Time Frame: 5 minutes each at Visits 4 and 43 ]
    Fasting blood draw on same day of MRI to measure change in serum BDNF from baseline to follow-up

  3. Memory test performance [ Time Frame: 1.5 to 2 hours each at Visits 4 and 43 ]
    Participants will perform recognition memory tests during and after functional MRI. Measurements include baseline-to-follow-up change in reaction times and accuracy.


Secondary Outcome Measures :
  1. Aerobic capacity and muscle strength [ Time Frame: 80 min each at Visits 2, 3, 41 and 42 ]
    Participants will perform two treadmill tests and several muscle strength tests to estimate baseline-to-follow-up change in aerobic capacity, measure change in time on treadmill, and determine change in muscle strength.


Other Outcome Measures:
  1. Blood cortisol levels [ Time Frame: 5 min each at Visits 4 and 43 ]
    Cortisol levels will be obtained from the blood sample drawn during baseline and follow-up.

  2. Anthropometric measurements [ Time Frame: 10 minutes each during Visits 2 and 41 ]
    Anthropometric measurements include height, weight, and body mass index. Percent body fat will also be estimated.

  3. Blood serum levels of other neurotrophins [ Time Frame: 5 min each at Visit 4 and 43 ]
    The blood draw will be used for other neurotrophins related to exercise and cognition.

  4. Neuropsychological test performance [ Time Frame: 15-30 minutes each at Visits 4 and 43 ]
    Baseline-to-follow-up change in performance of the Wechsler Adult Intelligence Scale-IV subtests



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 85 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Non-smoking
  • Age between 18-35 years or between 55-85 years
  • Sedentary status (physically inactive)
  • Generally healthy
  • Native-English speaker

Exclusion Criteria:

  • Diagnosis of severe anemia
  • Past or present condition that affect cognitive functioning:

    1. learning disability
    2. neurological disorders or conditions (movement disorder, history of head trauma or stroke, epilepsy, etc.)
    3. psychiatric disorders or conditions (depression, anxiety disorder, etc.)
  • Poor vision that cannot be corrected with glasses or contact lenses
  • Presence of an infection
  • Diagnosis of kidney failure
  • Diagnosis of liver disease
  • Diagnosis of thyrotoxicosis/hyperthyroidism
  • Diagnosis of cancer
  • Past or present conditions that are counter indicators for participation in cardio-respiratory fitness assessment and physical exercise:

    1. heart (e.g. heart attack, arrhythmias, etc.)
    2. circulatory (e.g. uncontrolled hypertension, high cholesterol, etc.)
    3. respiratory conditions (e.g., asthma or lung conditions, such as chronic obstructive pulmonary disease, acute bronchitis, acute common cold, lung cancer, pneumonia, etc.)
    4. current musculoskeletal impairments (e.g. leg claudication, fractures, hemiplegia, chronic joint pain, arthritis, osteoporosis, not able to walk comfortably without assistance, etc.)
    5. diagnosis of electrolyte disorder or abnormality
    6. presence of diabetes mellitus
  • Claustrophobia (fear of small, encloses spaces)
  • Female subjects: breast-feeding or potentially pregnant
  • Obesity
  • Eating disorder
  • Compulsive exercising
  • Ferro-magnetic metal in or on the body that cannot be removed (e.g. pacemaker, defibrillator, permanent tattoo or eyeliner with metallic specks)
  • Prescription medication or other drugs that are cardio-active
  • Prescription medication or other drugs that are psycho-active
  • Drug abuse or alcohol misuse
  • Regularly exercising
  • Unavailable for the approximately 4-month duration of the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02057354


Locations
Layout table for location information
United States, Massachusetts
Boston University School of Medicine
Boston, Massachusetts, United States, 02118
Sponsors and Collaborators
Boston University
National Institute on Aging (NIA)
Investigators
Layout table for investigator information
Principal Investigator: Karin Schon, PhD Boston University

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Karin Schon, Assisstant Professor, Department of Anatomy & Neurobiology, BUSM, Boston University
ClinicalTrials.gov Identifier: NCT02057354     History of Changes
Other Study ID Numbers: H-32635
R00AG036845 ( U.S. NIH Grant/Contract )
First Posted: February 7, 2014    Key Record Dates
Last Update Posted: April 25, 2018
Last Verified: April 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Karin Schon, Boston University:
Brain
Brain-Derived Neurotrophic Factor
Brain Mapping
Cognition
Exercise
Hippocampus
Hydrocortisone
Learning
Memory
Magnetic Resonance Imaging
Nerve Growth Factors
Neuroimaging
Physical Endurance
Physical Fitness
Resistance Training
Walking